Labyrinth Psychiatry Group

Labyrinth Psychiatry Group in Cranford, New Jersey offers Spravato (esketamine) for adults with treatment-resistant depression who have not found relief after trying multiple antidepressants, as well as for depressive symptoms in adults with major depressive disorder and suicidal thoughts. As the first FDA-approved depression medication that targets the brain's glutamate system, esketamine works differently than conventional antidepressants and often acts quickly.

The nasal spray is administered as three doses spaced five minutes apart while a provider observes, followed by at least two hours of monitoring before the patient is sent home.

A team of licensed mental health professionals carefully evaluates each treatment plan, recommending Spravato in specific cases for patients over 18 who have tried at least two antidepressants without adequate improvement. Telehealth appointments are also available alongside the practice's broader psychiatric services.